Skip to content
Awesome – Lifestyle
Author:
Jade Biosciences
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 29, 2026
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
April 29, 2026
←
Previous Page
1
2